Abstract

The present application relates to a process for the preparation of 2,2',2''-(1,4,7,10-Tetraazacyclododecane-1,4,7-triyl)triacetic acid represented by the following structural formula-3.

Formula-3.

Present disclosure also describes a novel crystalline form of Calteridol calcium and its process for the preparation.

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

Share

COinS